ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,3461
1,66%
Bitcoin
69.330,36
-2,03%
Brent Oil
79,395
-0,61%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Coherus BioSciences Inc (CHRS)

  7. Coherus BioSciences Inc (CHRS) Notícias

CHRS Coherus BioSciences Inc

1,73
-0,01 (-0,57%)
Após o horário de negociação
Última atualização: 19:00:08
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Coherus BioSciences Inc CHRS NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
-0,01 -0,57% 1,73 19:00:08
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,72 1,68 1,75 1,69 1,74
mais cotações »

Notícias Recentes

Data Hora Fonte Título
05/06/202410:00GLOBECoherus BioSciences Appoints Rita Karachun, CPA, CGMA to its..
30/05/202410:00GLOBECoherus Management to Present at the 2024 Jefferies Global..
23/05/202418:51GLOBECoherus Presents Preliminary Results from Phase I Dose..
23/05/202410:00GLOBECoherus Management to Present at the TD Cowen 5th Annual..
09/05/202417:01GLOBECoherus BioSciences Reports First Quarter 2024 Financial..
09/05/202408:30GLOBECoherus Announces Full Repayment of Pharmakon Advisors $75..
08/05/202410:00GLOBECoherus Announces Clinical Collaboration with the Cancer..
01/05/202417:30GLOBECoherus to Report First Quarter 2024 Financial Results on..
24/04/202411:02GLOBECoherus Announces Presentation at the 2024 American Society..
08/04/202409:30GLOBECoherus Presents Preclinical Data for CHS-1000, a Novel..
13/03/202417:01GLOBECoherus BioSciences Reports Fourth Quarter, Full Year 2023..
05/03/202418:01GLOBECoherus to Report Fourth Quarter and Full Year 2023..
04/03/202403:00GLOBECoherus Completes Divestiture of Ophthalmology Franchise
23/02/202419:33GLOBECoherus BioSciences Announces New Employment Inducement..
21/02/202410:30GLOBECoherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and..
05/02/202410:00GLOBECoherus Amends Term Loan Agreement with Pharmakon Advisors,..
22/01/202403:59DJNSandoz to Acquire Cimerli Business from Coherus for $170..
22/01/202403:15GLOBECoherus Announces Agreement to Divest Ophthalmology..
18/01/202418:05GLOBECoherus Presents Positive Phase 2 Clinical Data on..
04/01/202410:00PRNUSINOVIO and Coherus Announce Clinical Collaboration to..
03/01/202411:00GLOBECoherus BioSciences Management to Present at the 42nd Annual..
02/01/202410:29GLOBECoherus Announces U.S. Launch of LOQTORZI™
27/12/202311:15APSAnother Biotech Massively Outperforming Broader Equities
27/12/202308:08IHMARKETNEWSWall Street Highlights: Apple Appeals Watch Ban, Tesla to..
26/12/202318:43DJNCoherus BioSciences Gets FDA OK for Udenyca Injector
26/12/202318:01GLOBECoherus Announces FDA Approval of UDENYCA ONBODY™, a Novel..
22/12/202319:00GLOBECoherus BioSciences Announces New Employment Inducement..
11/12/202310:30GLOBECoherus Announces Updated NCCN Clinical Practice Guidelines..
07/12/202319:55GLOBECoherus BioSciences Announces CFO Transition Plans
06/12/202306:00GLOBECoherus Presents Phase 1/2 Clinical Data on Casdozokitug, a..
28/11/202313:16GLOBECoherus and Junshi Biosciences Announce Publication of..
06/11/202318:07GLOBECoherus BioSciences Reports Third Quarter 2023 Financial..
03/11/202309:30GLOBECoherus Presents Data from Next-generation Immuno-oncology..
02/11/202321:00GLOBECoherus BioSciences to Participate at Upcoming November..
30/10/202319:00GLOBECoherus BioSciences to Report Third Quarter 2023 Financial..
30/10/202307:37IHMARKETNEWSMonday’s Wall Street Highlights: HSBC, Ford, Coherus..
27/10/202318:55DJNCoherus BioSciences Shares Climb 12% on FDA Approval for..
27/10/202317:09DJNCoherus BioSciences Gets FDA Approval for Loqtorzi,..
27/10/202316:07GLOBECoherus and Junshi Biosciences Announce FDA Approval of..
24/10/202320:41GLOBECoherus BioSciences Announces New Employment Inducement..
14/10/202313:30GLOBECoherus Announces Toripalimab Data at 2023 AACR-NCI-EORTC..
05/10/202309:30GLOBECoherus Announces Resubmission of Biologics License..
04/10/202309:30GLOBECIMERLI® (ranibizumab-eqrn) Sales Exceed 100,000 Doses in..
02/10/202310:00GLOBECoherus Applauds Congressional Designation of September 30th..
27/09/202310:10GLOBECoherus Announces Three Presentations at the 38th Annual..
25/09/202317:17DJNCoherus BioSciences Shares Drop 9% on FDA's Application..
25/09/202310:24DJNCoherus: FDA Turns Away Udenyca On-Body Due to Filler Issues
25/09/202309:30GLOBEFDA Issues Complete Response Letter (CRL) for UDENYCA®..
22/09/202322:00GLOBECoherus BioSciences Announces New Employment Inducement..
08/09/202310:05GLOBECoherus Completes Surface Oncology Acquisition

Seu Histórico Recente

NASDAQ
CHRS
Coherus BioSciences
BIT
UV8B5E
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados